newsfilter
← Latest News
GlobeNewswire·

Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

CARY, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call